Read More Pharma Industry News Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth… bySrinathAugust 8, 2022
